Therapeutic targeting of Mammary cancer with a small molecule compound: Sulfretin suppresses the oncogenic Her2 and Her3 expression via up regulation of its target gene, 2/November/2013, 8.56 am

Therapeutic targeting of Mammary cancer with a small molecule compound: Sulfretin suppresses the oncogenic Her2 and Her3 expression via up regulation of its target gene, 2/November/2013, 8.56 am

Therapeutic targeting of Mammary cancer with a small molecule compound: Sulfretin suppresses the oncogenic Her2 and Her3 expression via up regulation of its target gene, 2/November/2013, 8.56 am 150 150

Idea Proposed byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, L,Therapeutic targeting of Mammary cancer with a small molecule compound: Sulfretin suppresses the oncogenic Her2 and Her3 expression via up regulation of its target gene, 2/November/2013, 8.56 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org